Bio Techne (Brazil) Market Value

T1CH34 Stock   13.44  1.06  7.31%   
Bio Techne's market value is the price at which a share of Bio Techne trades on a public exchange. It measures the collective expectations of Bio Techne investors about its performance. Bio Techne is trading at 13.44 as of the 22nd of November 2024, a 7.31% down since the beginning of the trading day. The stock's open price was 14.5.
With this module, you can estimate the performance of a buy and hold strategy of Bio Techne and determine expected loss or profit from investing in Bio Techne over a given investment horizon. Check out Bio Techne Correlation, Bio Techne Volatility and Bio Techne Alpha and Beta module to complement your research on Bio Techne.
Symbol

Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Techne's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Bio Techne 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bio Techne's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bio Techne.
0.00
10/23/2024
No Change 0.00  0.0 
In 31 days
11/22/2024
0.00
If you would invest  0.00  in Bio Techne on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Bio Techne or generate 0.0% return on investment in Bio Techne over 30 days. Bio Techne is related to or competes with Fras Le, BTG Pactual, Telefonaktiebolaget, Cable One, Randon SA, and Alphabet. More

Bio Techne Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bio Techne's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bio Techne upside and downside potential and time the market with a certain degree of confidence.

Bio Techne Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Bio Techne's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bio Techne's standard deviation. In reality, there are many statistical measures that can use Bio Techne historical prices to predict the future Bio Techne's volatility.
Hype
Prediction
LowEstimatedHigh
11.0113.4415.87
Details
Intrinsic
Valuation
LowRealHigh
9.1711.6014.03
Details
Naive
Forecast
LowNextHigh
10.8113.2415.67
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
12.6013.9215.24
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Bio Techne. Your research has to be compared to or analyzed against Bio Techne's peers to derive any actionable benefits. When done correctly, Bio Techne's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Bio Techne.

Bio Techne Backtested Returns

At this point, Bio Techne is not too volatile. Bio Techne secures Sharpe Ratio (or Efficiency) of 0.0199, which signifies that the company had a 0.0199% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Bio Techne, which you can use to evaluate the volatility of the firm. Please confirm Bio Techne's Downside Deviation of 3.88, mean deviation of 1.16, and Risk Adjusted Performance of 0.0215 to double-check if the risk estimate we provide is consistent with the expected return of 0.0484%. Bio Techne has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.35, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Bio Techne's returns are expected to increase less than the market. However, during the bear market, the loss of holding Bio Techne is expected to be smaller as well. Bio Techne right now shows a risk of 2.43%. Please confirm Bio Techne treynor ratio, value at risk, and the relationship between the sortino ratio and maximum drawdown , to decide if Bio Techne will be following its price patterns.

Auto-correlation

    
  -0.74  

Almost perfect reverse predictability

Bio Techne has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Bio Techne time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bio Techne price movement. The serial correlation of -0.74 indicates that around 74.0% of current Bio Techne price fluctuation can be explain by its past prices.
Correlation Coefficient-0.74
Spearman Rank Test-0.19
Residual Average0.0
Price Variance0.29

Bio Techne lagged returns against current returns

Autocorrelation, which is Bio Techne stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bio Techne's stock expected returns. We can calculate the autocorrelation of Bio Techne returns to help us make a trade decision. For example, suppose you find that Bio Techne has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Bio Techne regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bio Techne stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bio Techne stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bio Techne stock over time.
   Current vs Lagged Prices   
       Timeline  

Bio Techne Lagged Returns

When evaluating Bio Techne's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bio Techne stock have on its future price. Bio Techne autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bio Techne autocorrelation shows the relationship between Bio Techne stock current value and its past values and can show if there is a momentum factor associated with investing in Bio Techne.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Bio Stock

Bio Techne financial ratios help investors to determine whether Bio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bio with respect to the benefits of owning Bio Techne security.